In multiple myeloma (MM), a hematological malignancy characterized by the uncontrolled proliferation of plasma cells, several kinases, including AKT and B-cell receptor signaling (BCR) kinases, are known to be involved in tumorigenesis and therapy resistance [10,11,12,13]. Here, AKT1 is linked to Miyoshi myopathy.